- Home
- IREN vs TWST Comparison
IREN vs TWST Comparison
Compare IREN & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IREN
- TWST
- Stock Information
- Founded
- IREN 2018
- TWST 2013
- Country
- IREN Australia
- TWST United States
- Employees
- IREN N/A
- TWST N/A
- Industry
- IREN EDP Services
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IREN Technology
- TWST Health Care
- Exchange
- IREN Nasdaq
- TWST Nasdaq
- Market Cap
- IREN 2.5B
- TWST 2.3B
- IPO Year
- IREN 2021
- TWST 2018
- Fundamental
- Price
- IREN $18.99
- TWST $36.03
- Analyst Decision
- IREN Strong Buy
- TWST Buy
- Analyst Count
- IREN 10
- TWST 10
- Target Price
- IREN $19.22
- TWST $49.10
- AVG Volume (30 Days)
- IREN 32.7M
- TWST 881.1K
- Earning Date
- IREN 08-27-2025
- TWST 08-04-2025
- Dividend Yield
- IREN N/A
- TWST N/A
- EPS Growth
- IREN N/A
- TWST N/A
- EPS
- IREN N/A
- TWST N/A
- Revenue
- IREN $377,821,000.00
- TWST $347,680,000.00
- Revenue This Year
- IREN $168.58
- TWST $22.75
- Revenue Next Year
- IREN $79.94
- TWST $17.74
- P/E Ratio
- IREN N/A
- TWST N/A
- Revenue Growth
- IREN 128.24
- TWST 25.30
- 52 Week Low
- IREN $5.13
- TWST $27.12
- 52 Week High
- IREN $21.54
- TWST $60.90
- Technical
- Relative Strength Index (RSI)
- IREN 81.39
- TWST 50.70
- Support Level
- IREN $17.49
- TWST $34.16
- Resistance Level
- IREN $21.54
- TWST $38.60
- Average True Range (ATR)
- IREN 1.69
- TWST 1.62
- MACD
- IREN 0.01
- TWST -0.36
- Stochastic Oscillator
- IREN 59.91
- TWST 35.89
About IREN Iris Energy Limited
IREN Ltd is engaged in data center business powering the future of Bitcoin, AI and beyond utilizing renewable energy.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.